Prophylaxis of graft-versus-host disease in unrelated donor transplantation with pentostatin, tacrolimus, and mini-methotrexate: a phase I/II controlled, adaptively randomized study
about
Current and emerging strategies for the prevention of graft-versus-host diseaseDose intensification of busulfan in the preparative regimen is associated with improved survival: a phase I/II controlled, randomized study.Significance of persistent cytogenetic abnormalities on myeloablative allogeneic stem cell transplantation in first complete remission.Graft-versus-host disease: state of the science.Have we improved in preventing and treating acute graft-versus-host disease?Prevention of graft-vs.-host diseaseApproaches for the prevention of graft-versus-host disease following hematopoietic cell transplantationAnti-thymocyte globulin (thymoglobulin), tacrolimus, and sirolimus as acute graft-versus-host disease prophylaxis for unrelated hematopoietic stem cell transplantation.Optimizing management of myelodysplastic syndromes post-allogeneic transplantation.Novel approaches for preventing acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.Interactions Between Inflammatory Bowel Disease Drugs and Chemotherapy.Pentostatin therapy for steroid-refractory acute graft versus host disease: identifying those who may benefit.Blood and Marrow Transplant Clinical Trials Network Report on the Development of Novel Endpoints and Selection of Promising Approaches for Graft-versus-Host Disease Prevention Trials.Genetic polymorphisms predicting methotrexate blood levels and toxicity in adult non-Hodgkin lymphoma.The Role of Extracellular Adenosine Generation in the Development of Autoimmune Diseases.
P2860
Q27016541-3C03DB2E-6B99-4BA5-A2FE-DFE9428D5BB6Q33737884-BC316D26-9914-45DD-95A9-4038650720A3Q33931553-322BDEE2-2C10-4D5F-8768-A43AEB945D43Q33977923-D22313E7-B1FC-4293-9385-11DFB66A279EQ36203692-0C6FC975-CB89-4C3E-8CFB-3E3A28D02259Q36431047-37078D57-456D-4B4E-A9B4-0089CECE9EC7Q36891433-1ACF1283-D005-49B4-A91B-F7DC3F479094Q37184046-D168B126-52B7-410F-9857-C23AAAA2EC5CQ37955235-145F7082-5274-4D0E-BC4F-93E542AFBD1CQ38816505-1039D815-C3F8-472F-ACA6-37E1947ACC4BQ38973323-149C01D8-E63A-471F-8AAB-4184A504AED6Q48362201-AD9DFD97-A92B-4086-A3B0-29231986E853Q50079874-3C6F94E3-AD73-4F1F-979C-A5FEE3686769Q50856551-5259B2FA-F655-4D73-9893-5DB49C5DC7F7Q55261560-C24E2A05-6436-4E15-B985-15BABE1C4D89
P2860
Prophylaxis of graft-versus-host disease in unrelated donor transplantation with pentostatin, tacrolimus, and mini-methotrexate: a phase I/II controlled, adaptively randomized study
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Prophylaxis of graft-versus-ho ...... d, adaptively randomized study
@ast
Prophylaxis of graft-versus-ho ...... d, adaptively randomized study
@en
Prophylaxis of graft-versus-ho ...... d, adaptively randomized study
@nl
type
label
Prophylaxis of graft-versus-ho ...... d, adaptively randomized study
@ast
Prophylaxis of graft-versus-ho ...... d, adaptively randomized study
@en
Prophylaxis of graft-versus-ho ...... d, adaptively randomized study
@nl
prefLabel
Prophylaxis of graft-versus-ho ...... d, adaptively randomized study
@ast
Prophylaxis of graft-versus-ho ...... d, adaptively randomized study
@en
Prophylaxis of graft-versus-ho ...... d, adaptively randomized study
@nl
P2093
P2860
P356
P1476
Prophylaxis of graft-versus-ho ...... d, adaptively randomized study
@en
P2093
Amin Alousi
Borje S Andersson
Chitra Hosing
Daniel Couriel
Donald Berry
Doyle Bosque
Elizabeth J Shpall
J Kyle Wathen
Leandro de Padua Silva
Marcelo Fernandez-Vina
P2860
P304
P356
10.1200/JCO.2010.30.6357
P407
P577
2010-12-13T00:00:00Z